1HAVLIK R J. Vitamin E and wound healing: safety and efficacy reports [J]. Plast Reconstruct Surg, 1997 : 1901-1902.
2EHRLICH H P, DESMOUKIERE A, DLEGELAMN R F, et al.Morphologied and immumothemical differences between keloid and hypertrophic scar[J]. Am J Patho I,1994,145-105.
4KAW AGUCHI Y,TAKAGI K,HARA M,et al. Angiotensin Ⅱ in the lesional skin of systemic scleros is patients contributes to tissue fibrosis via angiotensin Ⅱ type 1 receptor [J]. Arthritis Rheum,2004,50(1) :216-226
5NAKAZONO-KUSABA A, TAKAHASHI-YANAGA F, MORIMOTO S, et al. Staurosporine-induced cleavage of alpha-smooth muscle actin during myofibroblast apoptosis[J]. J Invest Dermatol, 2002,119(5) : 1008-1013.
6VAN BEURDEN H E,VON DEN HOFF J W,TORENSMA R,et al. Myofibroblasts in palatal wound healing,prospects for the reduction of wound contraction after cleft palate repair[J]. J Dent Res, 2005,84 (10) : 871-880.
7DESMOULIERE A,CHAPONNIER C,GABBIANI G. Tissue repair,contraction,and the myofibroblast[J]. Wound Repair Regen, 2005,13(1) :7-12.
9CHOWDRI N A,MATTOO MMA,DARZI MA. Keloids and hyphertrophic acars:results with Intraoperative and serial postoperative corticosteroid unjection therapy[J]. Aust N S J Surg, 1999, 69:655-659.
10SCLAFANI A P,GORDON L,CHADHA M,et al. Prevention of earlobe keloid reeurrenee with postoperative corticoteroid injections versus radiation therapy: a randomized prospective study and review of the literature[J]. Dermatol Surg,1996,22(2):569- 576.
2[1]Marneros AG,Norris JE,Olsen BR,et al.Clinical genetics of familial keloids[J].Arch Dermatol,2001,137(11):1429-1434.
3[2]Kim A,DiCarlo J,Cohen C,et al.Are keloids really"gli-loids"?:High-level expression of gli-1 oncogene in keloids[J].J Am Acad Dermatol,2001,45(5):707-711.
4[3]Naiton M,Hosokawa N,Kubota H,et al.Upregulation of HSP47 and collagen type Ⅲ in the dermal fibrotic disease, keloid[J].Biochem Biophys Res Commun,2001,280(5):1316-1322.
5[4]Norris JE.Superficial X-ray therapy in keloids management: a retrospective study of 24 cases and literature review[J].Plast Reconstr Surg,1995,95(6):1051-1055.
9Neneth AJ. keloids and hypertrophic scar [J]. J Dermstol Surgoncol,1993,19(8) :738-746.
10Niessen FB, Spauwen PHM, Schalkwijk. J, et al. On the nature of hypertr ophic and keloids : a review [ J ]. Plast Reconstr Surg , 1999,104(5) :1435 - 1458.
3Fitzpatrick RE.Treatment of inflamed hypertrophic scars using intralesional 5-Fu[J].Dermal Surg,2003,25(3):224-232.
4Lee JP,Jalili RB,Tredget EE,et al.Antifibrogenic efects of lipo- some-encapsulated IFN-alpha2b cream on skin wounds in a fi- brotic rabbit ear model[J].J Interferon Cytokine Res,2005,25(10): 627 - 631.
5Choi BM,Kwak HJ,Jun CD,et al .Control of scarring in adult wounds using antisense transforming growth factor-beta 1 oligode- oxynucleotides[J].Immunol Cell Biol,1996,74(2): 144 - 150.
6Takahashi Y, Takahashi S,Shiga Y, et al.Hypoxic induction of prolyl 42 hydroxylase alpha (I) in cultured cells[J].Biol Chem,2000,275: 14139- 14146.
7Falanga V,Qian SW,Danielpour D,et al.Hypoxia upregulates the syn2 thesis of TGF2betal by human dermal fibroblasts[J].J Invest Dermatol, 1991,97:634- 637.
